3.3 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

Medtronic has received 65.15% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Medtronic and other stocks. Vote “Outperform” if you believe MDT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MDT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Miscellaneous

Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

Medtronic (NYSE:MDT) Frequently Asked Questions

How has Medtronic's stock been impacted by COVID-19 (Coronavirus)?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDT shares have increased by 10.4% and is now trading at $102.04. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Medtronic?

30 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 1 sell rating, 6 hold ratings, 22 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Medtronic.

When is Medtronic's next earnings date?

How were Medtronic's earnings last quarter?

Medtronic PLC (NYSE:MDT) announced its quarterly earnings data on Thursday, May, 21st. The medical technology company reported $0.58 EPS for the quarter, missing the Zacks' consensus estimate of $1.28 by $0.70. The medical technology company earned $6 billion during the quarter, compared to the consensus estimate of $6.10 billion. Medtronic had a net margin of 16.56% and a return on equity of 12.17%. Medtronic's revenue for the quarter was down 26.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.54 EPS. View Medtronic's earnings history.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Thursday, May 21st. Investors of record on Friday, June 26th will be paid a dividend of $0.58 per share on Friday, July 17th. This represents a $2.32 annualized dividend and a yield of 2.27%. The ex-dividend date of this dividend is Thursday, June 25th. This is a positive change from Medtronic's previous quarterly dividend of $0.54. View Medtronic's dividend history.

What price target have analysts set for MDT?

30 brokerages have issued 1-year price targets for Medtronic's stock. Their forecasts range from $92.00 to $135.00. On average, they anticipate Medtronic's share price to reach $114.53 in the next year. This suggests a possible upside of 12.2% from the stock's current price. View analysts' price targets for Medtronic.

What are Wall Street analysts saying about Medtronic stock?

Here are some recent quotes from research analysts about Medtronic stock:

Has Medtronic been receiving favorable news coverage?

Headlines about MDT stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medtronic earned a daily sentiment score of -1.1 on InfoTrie's scale. They also assigned press coverage about the medical technology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future. View the latest news aboutMedtronic.

Which institutional investors are selling Medtronic stock?

MDT stock was sold by a variety of institutional investors in the last quarter, including 1832 Asset Management L.P., BlackRock Inc., Primecap Management Co. CA, Wellington Management Group LLP, Canada Pension Plan Investment Board, Manning & Napier Group LLC, Balyasny Asset Management LLC, and Public Sector Pension Investment Board. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Carol A Surface, Geoffrey Martha, Hooman Hakami, Michael J Coyle, Richard Kuntz, and Robert John White. View insider buying and selling activity for Medtronic.

Which institutional investors are buying Medtronic stock?

MDT stock was acquired by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., APG Asset Management N.V., APG Asset Management N.V., Swiss National Bank, Bank of New York Mellon Corp, Fisher Asset Management LLC, Morgan Stanley, and Cullen Capital Management LLC. Company insiders that have bought Medtronic stock in the last two years include Karen L Parkhill, Omar Ishrak, and Richard H Anderson. View insider buying and selling activity for Medtronic.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $102.04.

How big of a company is Medtronic?

Medtronic has a market capitalization of $136.75 billion and generates $28.91 billion in revenue each year. The medical technology company earns $4.79 billion in net income (profit) each year or $4.59 on an earnings per share basis. Medtronic employs 90,000 workers across the globe.